Superficial Accumulation of Plasminogen During Plasma Clot Lysis
- 1 October 1995
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 92 (7) , 1883-1890
- https://doi.org/10.1161/01.cir.92.7.1883
Abstract
Background Binding of plasminogen to partially degraded fibrin is an important step in fibrinolysis, influencing its rate and fibrin specificity. Little is known about the spatial distribution of plasminogen and of plasminogen-binding sites inside thrombi during lysis. In the present study, we investigated this problem, which is important for a better understanding of the local regulation of fibrinolysis and the rate-limiting factors of therapeutic thrombolysis. Methods and Results An experimental system was used that allowed continuous visualization and quantification by fluorescence microscopy of the spatial distribution of fluorescein-labeled plasminogen inside and outside model thrombi. Strong superficial accumulation of plasminogen was observed during lysis of a plasma clot induced by tissue-type or urokinase-type plasminogen activators in the surrounding plasma. A distinctly visible plasminogen-accumulating shell moved continuously with the reducing surface of the clot. The accumulation decreased in conditions of exhaustive activation of plasminogen in the outer plasma. It was found in a purified system that a thin superficial layer (≈50 μm wide) of a plasmin-treated fibrin clot exposes about 2.5 plasminogen-binding sites per fibrin monomer with a K d of 2.2 μmol/L. At a physiological concentration of plasminogen (1.5 μmol/L) in the outer medium, plasminogen was concentrated about 10-fold in this layer. The binding was dose-dependently inhibited by ε-aminocaproic acid. Conclusions We conclude that the generation of potent surface-associated plasminogen-binding sites during thrombolysis results in a strikingly high plasminogen concentration at the dynamically changing surface of a lysing clot. The necessity of a continuous plasminogen supply from the plasma supports the use of fibrin-specific and plasminogen-sparing agents for thrombolytic therapy.Keywords
This publication has 30 references indexed in Scilit:
- Interaction between plasminogen activator inhibitor type 1 (PAI-1) bound to fibrin and either tissue-type plasminogen activator (t-PA) or urokinase-type plasminogen activator (u-PA). Binding of t-PA/PAI-1 complexes to fibrin mediated by both the finger and the kringle-2 domain of t-PA.Journal of Clinical Investigation, 1989
- Binding of plasminogen activators to fibrin: characterization and pharmacological consequencesBiochemical Journal, 1989
- Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.Journal of Clinical Investigation, 1988
- Kinetic studies on the interaction of streptokinase and other plasminogen activators with plasminogen and fibrinBiochemical Journal, 1985
- Quantitative characterization of the binding of plasminogen to intact fibrin clots, lysine-Sepharose, and fibrin cleaved by plasminBiochemistry, 1985
- The activation of GLU- and LYS-plasminogens by streptokinase: Effects of fibrin, fibrinogen and their degradation productsThrombosis Research, 1985
- Tissue-type plasminogen activator increases the binding of glu-plasminogen to clots.Journal of Clinical Investigation, 1984
- Initial plasmin-degradation of fibrin as the basis of a positive feed-back mechanism in fibrinolysisEuropean Journal of Biochemistry, 1984
- Cross-linking of alpha 2-plasmin inhibitor to fibrin by fibrin-stabilizing factor.Journal of Clinical Investigation, 1980
- Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degradation influence of ω-aminocarboxylic acidsBiochimica et Biophysica Acta (BBA) - Protein Structure, 1975